Person

Jennifer B. Damico

SVP & Controller, Pfizer

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$1.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 5, 2026PFESale3,278$25.40$83K
Jun 9, 2026PFESale2,000$25.70$51K
Mar 4, 2025PFESale2,500$25.93$65K
Aug 13, 2024PFESale5,154$28.66$148K
Mar 15, 2023PFESale9,912$40.02$397K
Jun 7, 2022PFESale4,218$53.96$228K
May 16, 2022PFESale4,000$50.50$202K
Aug 13, 2021PFESale1,660$48.30$80K
Aug 13, 2021PFESale1$48.29$48
Jul 30, 2021PFESale2,500$42.86$107K
May 5, 2021PFESale2,500$40.82$102K
Jun 5, 2020PFESale2,181$36.13$79K
Apr 29, 2020PFESale2,181$38.35$84K

SEC reporting-owner ID (CIK) 1805617 · all filings on EDGAR